Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Liabilities and Shareholders Equity (2021 - 2025)

Coeptis Therapeutics Holdings (COEP) has 5 years of Liabilities and Shareholders Equity data on record, last reported at $14.2 million in Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity rose 58.35% year-over-year to $14.2 million; the TTM value through Sep 2025 reached $48.7 million, up 125.42%, while the annual FY2024 figure was $8.9 million, 94.89% up from the prior year.
  • Liabilities and Shareholders Equity reached $14.2 million in Q3 2025 per COEP's latest filing, up from $12.2 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $76.6 million in Q1 2021 and bottomed at $3.9 million in Q1 2024.
  • Average Liabilities and Shareholders Equity over 5 years is $25.0 million, with a median of $9.0 million recorded in 2024.
  • Peak YoY movement for Liabilities and Shareholders Equity: tumbled 92.18% in 2023, then soared 245.45% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $6.8 million in 2021, then grew by 17.0% to $7.9 million in 2022, then crashed by 42.25% to $4.6 million in 2023, then skyrocketed by 94.89% to $8.9 million in 2024, then skyrocketed by 59.19% to $14.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $14.2 million in Q3 2025, $12.2 million in Q2 2025, and $13.5 million in Q1 2025.